CIPROFLOXACIN

Generic: CIPROFLOXACIN, CIPROFOLXACIN, CIPROFLOXACIN TABLETS

Method PharmaceuticalsManufacturer
ORALRoute
CIPROFLOXACIN HYDROCHLORIDEActive Substance
2018-06-22Original Approval

CIPROFLOXACIN is FDA application ANDA208921, sponsored by PHARMOBEDIENT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2013-02-06
Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntow

Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ci

Class II2024-12-16
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading

Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged

Class II2025-08-13
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manuf

Temperature Abuse

Class II2025-03-11
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LL

Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged

Class II2019-07-02
Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, 10 mL, Rx only, Altaire Pharmaceuticals, Inc. Aquebogue, NY 1193

Lack of Assurance of Sterility

Class II2019-07-02
Altaire Ciprofloxacin HCl Ophthalmic Solution, 0.3%, 5 mL, NDC 59390-217-05

Lack of Assurance of Sterility

Class II2019-07-02
Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 N

Lack of Assurance of Sterility

Class II2024-07-23
Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 693

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged

Class II2026-10-20
Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, A

CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

Class II2022-04-13
Ciprofloxacin Ophthalmic Solution 0.3%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-656-05

cGMP deviations: Temperature abuse

Top Reported Reactions

1
FATIGUE
4,846 reports
2
PAIN
4,710 reports
3
NAUSEA
4,658 reports
4
DIARRHOEA
4,640 reports
5
DRUG INEFFECTIVE
4,411 reports
6
ACUTE KIDNEY INJURY
4,400 reports
7
ARTHRALGIA
4,380 reports
8
CHRONIC KIDNEY DISEASE
4,113 reports
9
DRUG HYPERSENSITIVITY
3,998 reports
10
OFF LABEL USE
3,958 reports